Wezlana Co-Pay Program (Amgen SupportPlus)
Amgen Inc. · Wezlana
Patient pays: As little as $0 out-of-pocket per fill, dose, or cycle
commercial insurance
Patient assistance
Tell us your insurance and household details. We’ll show you every Wezlana assistance program you may qualify for - the real manufacturer and foundation programs, not a discount card - with sources and a direct link to apply. About a minute, no login.
Every Wezlana program linked to its official source, with the date we checked it - rules, income limits, and application links included.
Wezlana (ustekinumab-auub) is an il-12/il-23 inhibitor (biologic); ustekinumab biosimilar (references stelara) made by Amgen. It is commonly prescribed for: Plaque psoriasis, Psoriatic arthritis, Crohn's disease, Ulcerative colitis.
At a glance
As of July 2026, mendmeds tracks 2 Wezlana assistance programs, 1 of which is open to patients with no insurance.
Tell us five things. We’ll do the rest.
Reference
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
Amgen Inc. · Wezlana
Patient pays: As little as $0 out-of-pocket per fill, dose, or cycle
commercial insurance
Amgen Safety Net Foundation · Wezlana
uninsured
We couldn’t confirm the current terms - call the program to verify.
Common questions
Related drugs